Epstein Barr Virus Infection

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

Among patients with COPD and sputum Epstein-Barr virus, valaciclovir three times a day for 8 weeks helped more individuals suppress the virus than placebo, according to study results published in CHEST.

SAN DIEGO — Evidence over the past 10 years supports the role of Epstein-Barr virus in the development of MS, according to a presenter at ACTRIMS 2023.

Healio compiled the most-read news in allergy, asthma and immunology posted in October.

Epstein-Barr virus replication may be a cofactor in a subgroup of patients who develop long COVID fatigue, although other potential contributing factors need to be evaluated as well, according to a letter published in Allergy.

Healio’s most-viewed neurology stories in January highlight several FDA developments, a Medicare proposal to limit Aduhelm coverage and a study on the role of Epstein-Barr virus infection in MS.

Epstein-Barr virus infection, which causes mononucleosis, may represent a primary cause of MS, according to results of a longitudinal analysis published in Science.

The FDA granted orphan drug designation to nanatinostat and valganciclovir for treatment of Epstein Barr virus-positive diffuse large B-cell lymphoma not otherwise specified.